Figure 1.

CK2α overexpression is associated with decreased RFS in patients with ER (+) breast cancer. Using KMPlotter, we interrogated publically available microarray repositories for breast cancer to determine if CK2α expression was associated with different survival rates among ERα (+) and ERα (−) breast cancer patients. Hazard ratio (HR) and Logrank P values are shown. Low expression of CK2α expression (below median) is noted in black, and the high CK2α expression (above median) is noted in red.